"}
SHEN26 (ATY014) is a potent and orally active RdRp inhibitor, with an IC 50 for SARS-CoV-2 is 1.36 μM. SHEN26 is a 5’-cyclohexanecarboxylate derivative of GS-441524. SHEN26 inhibits viral nucleic acid synthesis to achieve antiviral effects. SHEN26 can be used for the research of coronavirus disease 2019 (COVID-19).
| CAS | 2691076-98-7 |
|---|---|
| Specifications & Purity | ≥99% |
| Storage | Store at 2-8°C |
| Shipped In | Wet ice |
| Product Description | SHEN26 (ATY014) is a potent and orally active RdRp inhibitor, with an IC 50 for SARS-CoV-2 is 1.36 μM. SHEN26 is a 5’-cyclohexanecarboxylate derivative of GS-441524. SHEN26 inhibits viral nucleic acid synthesis to achieve antiviral effects. SHEN26 can be used for the research of coronavirus disease 2019 (COVID-19). |